Rare Blood

Latest News

Blood for Transfusion PNH Concept | image credit: sebgross - stock.adobe.com
Pegcetacoplan Contributes to Better Outcomes in PNH vs Other Treatments

May 29th 2024

An analysis of 2 phase 3 trials supporting the use of pegcetacoplan (PEG) in the treatment of paroxysmal nocturnal hemoglobinuria (PNH) assessed the benefits of this treatment compared with eculizumab (ECU) and supportive care measures.

Hands Holding Newborn Baby | image credit: BazziBa - stock.adobe.com
SCD Birth Rate Higher in Socially Vulnerable Areas, Study Finds

May 9th 2024

Immune Cells and Antibodies Concept | image credit: vipman4 - stock.adobe.com
Immune Irregularities Detected in Patients With PNH

May 4th 2024

Electronic Health Record Access | image credit: pandpstock001 - stock.adobe.com
EHR Alerts Improve Quality of Care in Heparin-Induced Thrombocytopenia, Study Finds

April 30th 2024

Blood Transfusion | image credit: Kiryl Lis - stock.adobe.com
Exagamglogene Autotemcel Shows Promise in Treatment of Transfusion-Dependent β-Thalassemia

April 30th 2024

CH LogoCenter for Biosimilars Logo